Today’s public service announcement is that Congress wants to hear from you on a regulatory fix for cannabidiol (CBD) and other hemp-derived cannabinoid products. The request came down via the Energy and Commerce Committee on July 27, when it published a Request for Information (RFI) to “interested parties” on the topic. The deadline for RFI responses is August 18, 2023. You can email your thoughts on or before that date to CBD@mail.house.gov and CBD@help.senate.com.
Why is this happening now? The short answer is that Congress has another shot at the Farm Bill, which is the primary food and policy instrument of the federal government. In 2018, the Farm Bill removed hemp (and hemp-derived CBD) from the Controlled Substances Act. The Farm Bill is renewed every five years, so policymakers are ramping up for the 2023 version on pertinent topics– including CBD and other hemp-derived cannabinoids.
A better regulatory environment for CBD and hemp-derived cannabinoids is sorely needed. Commerce has outstripped regulations and enforcement is lax. The Food and Drug Administration (FDA) knows this, and published a statement earlier this year, awkwardly titled “Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a
Read full article on HarrisBricken
